Abstract:Inflammatory bowel disease (IBD) is a significant global health problem that involves chronic intestinal inflammation and can involve severe comorbidities, including intestinal fibrosis and inflammation-associated colorectal cancer (CRC). Disease-associated alterations to the intestinal microbiota often include fecal enrichment of Enterobacteriaceae , which are strongly implicated in IBD development. This dysbiosis of intestinal flora accompanies changes in microbial metabolites, shaping host:microbe interactions and disease risk. While there have been numerous studies linking specific bacterial taxa with IBD development, our understanding of microbial function in the context of IBD is limited. Several classes of microbial metabolites have been directly implicated in IBD disease progression, including bacterial siderophores and genotoxins. Yet, our microbiota still harbors thousands of uncharacterized microbial products. In-depth discovery and characterization of disease-associated microbial metabolites is necessary to target these products in IBD treatment strategies. Towards improving our understanding of microbiota metabolites in IBD, it is important to recognize how host relevant factors influence microbiota function. For example, changes in host inflammation status, metal availability, interbacterial community structure, and xenobiotics all play an important role in shaping gut microbial ecology. In this minireview, we outline how each of these factors influences gut microbial function, with a specific focus on IBD-associated Enterobacteriaceae metabolites. Importantly, we discuss how altering the intestinal microenvironment could improve the treatment of intestinal inflammation and associated disorders, like intestinal fibrosis and CRC.

New insights into the interplay between intestinal flora and bile acids in inflammatory bowel disease

The influence of bile acid, microbiota and their interaction on inflammatory bowel disease and the related progress in clinical application

Bile Acids and Microbiota: Multifaceted and Versatile Regulators of the Liver–Gut Axis

Bile Acid–Gut Microbiota Axis in Inflammatory Bowel Disease: From Bench to Bedside

Gut microbiota and inflammatory bowel disease: The current status and perspectives

Bile acids as inflammatory mediators and modulators of intestinal permeability

Interactive Relationships Between Intestinal Flora and Bile Acids.

Regulation of gut microbiota-bile acids axis by probiotics in inflammatory bowel disease

Emerging roles of bile acids in mucosal immunity and inflammation

Novel approaches in IBD therapy: targeting the gut microbiota-bile acid axis

The interaction of bile acids and gut inflammation influences the pathogenesis of inflammatory bowel disease

Intestinal Crosstalk between Bile Acids and Microbiota in irritable bowel syndrome

Bile Acid Signaling in Inflammatory Bowel Diseases

Bile Acids, Intestinal Barrier Dysfunction, and Related Diseases

Interactions between Intestinal Microbiota and Host Immune Response in Inflammatory Bowel Disease.

Gut microbial metabolome in inflammatory bowel disease: From association to therapeutic perspectives

Role of bile acids in liver diseases mediated by the gut microbiome

Microenvironmental Factors that Shape Bacterial Metabolites in Inflammatory Bowel Disease

The gut microbes in inflammatory bowel disease: Future novel target option for pharmacotherapy

The Potential Role of Phytonutrients Flavonoids Influencing Gut Microbiota in the Prophylaxis and Treatment of Inflammatory Bowel Disease

Bile Acid-Related Regulation of Mucosal Inflammation and Intestinal Motility: From Pathogenesis to Therapeutic Application in IBD and Microscopic Colitis